Transport and cytotoxicity of amino acid nitrogen mustards: implications for the design of more selective antitumor agents.
D000596:Amino Acids / Q000378:metabolism; D000818:Animals; D000970:Antineoplastic Agents / Q000378:metabolism / Q000633:toxicity; D001692:Biological Transport; D002470:Cell Survival; D006412:Hematopoietic Stem Cells / Q000187:drug effects / Q000378:metabolism; D006801:Humans; D007939:Leukemia L1210 / Q000188:drug therapy / Q000378:metabolism / Q000473:pathology; D008558:Melphalan / Q000378:metabolism / Q000494:pharmacology* / Q000633:toxicity; D009588:Nitrogen Mustard Compounds / Q000378:metabolism / Q000494:pharmacology* / Q000633:toxicity
D000596:Amino Acids; D000970:Antineoplastic Agents; D009588:Nitrogen Mustard Compounds; C050029:2-amino-6(7)-(bis(2-chloroethyl)amino)-1,2,3,4-tetrahydro-2-naphthalencarboxylic acid; D008558:Melphalan